Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Adebrelimab + HRS-4642 |
| Synonyms | |
| Therapy Description | |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Adebrelimab | SHR 1316|SHR1316|HTI 1088|HTI-1088|HTI1088|SHR-1316 | Immune Checkpoint Inhibitor 150 PD-L1/PD-1 antibody 141 | Adebrelimab is a monoclonal antibody that targets CD274 (PD-L1), potentially resulting in antitumor activity (PMID: 33760397). | |
| HRS-4642 | HRS 4642|HRS4642 | KRAS G12D Inhibitor 26 | HRS-4642 inhibits KRAS G12D, potentially resulting in antitumor activity (PMID: 38942026). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|